S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
pixel
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
What's in Democrats' big bill? Climate, health care, savings
Dems push Biden climate, health priorities toward Senate OK
Shift in war's front seen as grain leaves Ukraine; plant hit
pixel
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
pixel
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
What's in Democrats' big bill? Climate, health care, savings
Dems push Biden climate, health priorities toward Senate OK
Shift in war's front seen as grain leaves Ukraine; plant hit
pixel
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
pixel
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
What's in Democrats' big bill? Climate, health care, savings
Dems push Biden climate, health priorities toward Senate OK
Shift in war's front seen as grain leaves Ukraine; plant hit
pixel
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
pixel
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
What's in Democrats' big bill? Climate, health care, savings
Dems push Biden climate, health priorities toward Senate OK
Shift in war's front seen as grain leaves Ukraine; plant hit
pixel
LON:SN

Smith & Nephew - SN Share Forecast, Price & News

GBX 1,070.50
-10.00 (-0.93%)
(As of 08/5/2022 12:00 AM ET)
Add
Compare
Today's Range
1,064
1,081.50
50-Day Range
1,018.50
1,321.50
52-Week Range
1,002
1,440.89
Volume
3.14 million shs
Average Volume
343,671 shs
Market Capitalization
£9.34 billion
P/E Ratio
2,277.66
Dividend Yield
2.92%
Price Target
GBX 1,476.60

Smith & Nephew MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
37.9% Upside
GBX 1,476.60 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.95
Upright™ Environmental Score
News Sentiment
-0.48mentions of Smith & Nephew in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
£123.57 M Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.25 out of 5 stars

SN stock logo

About Smith & Nephew (LON:SN) Stock

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Receive SN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Smith & Nephew and its competitors with MarketBeat's FREE daily newsletter.

SN Stock News Headlines

Which way now for the Smith amp; Nephew share price?
1 FTSE 100 stock to buy and hold!
See More Headlines
Receive SN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Smith & Nephew and its competitors with MarketBeat's FREE daily newsletter.

SN Company Calendar

Ex-Dividend for 5/11 Dividend
3/31/2022
Dividend Payable
5/11/2022
Today
8/07/2022

Industry, Sector and Symbol

Industry
Medical Appliances & Equipment
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
18,369
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
GBX 1,476.60
High Stock Price Forecast
GBX 1,700
Low Stock Price Forecast
GBX 1,243
Forecasted Upside/Downside
+37.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
6 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£5.21 billion
Cash Flow
GBX 60.05 per share
Book Value
GBX 615.70 per share

Miscellaneous

Free Float
N/A
Market Cap
£9.34 billion
Optionable
Optionable
Beta
N/A

Key Executives

  • Ms. Anne-Francoise Nesmes (Age 50)
    CFO & Exec. Director
    Comp: $1.71M
  • Dr. Deepak S. Nath Ph.D. (Age 49)
    CEO & Director
  • Mr. Paul Connolly (Age 54)
    Pres of Global Operations
  • Mr. Andrew Swift
    VP of Investor Relations
  • Ms. Helen Barraclough (Age 43)
    Group Gen. Counsel, Company Sec. & Director
  • Ms. Alison Parkes (Age 50)
    Chief Compliance Officer
  • Mr. Joe Metzger
    Sr. VP of Marketing Services & Communications
  • Ms. Elga Lohler (Age 54)
    Chief HR Officer
  • Mr. Philip G. Cowdy (Age 55)
    Chief Bus. Devel. & Corp. Affairs Officer
  • Mr. Bradley Cannon (Age 54)
    Pres of Orthopaedics, Sports Medicine & ENT and Americas













SN Stock - Frequently Asked Questions

Should I buy or sell Smith & Nephew stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Smith & Nephew stock.
View analyst ratings for Smith & Nephew
or view top-rated stocks.

What is Smith & Nephew's stock price forecast for 2022?

6 equities research analysts have issued 1 year price objectives for Smith & Nephew's shares. Their SN stock forecasts range from GBX 1,243 to GBX 1,700. On average, they anticipate Smith & Nephew's stock price to reach GBX 1,476.60 in the next twelve months. This suggests a possible upside of 37.9% from the stock's current price.
View analysts' price targets for Smith & Nephew
or view top-rated stocks among Wall Street analysts.

How has Smith & Nephew's stock price performed in 2022?

Smith & Nephew's stock was trading at GBX 1,293.50 on January 1st, 2022. Since then, SN shares have decreased by 17.2% and is now trading at GBX 1,070.50.
View the best growth stocks for 2022 here
.

How often does Smith & Nephew pay dividends? What is the dividend yield for Smith & Nephew?

Smith & Nephew declared a dividend on Thursday, July 28th. Investors of record on Thursday, September 29th will be paid a dividend of GBX 0.14 per share on Wednesday, October 26th. This represents a yield of 0.99%. The ex-dividend date of this dividend is Thursday, September 29th. The official announcement can be seen at this link.
View Smith & Nephew's dividend history
.

Is Smith & Nephew a good dividend stock?

Smith & Nephew(LON:SN) pays an annual dividend of GBX 30 per share and currently has a dividend yield of 2.92%. The dividend payout ratio of Smith & Nephew is 6,382.98%. Payout ratios above 75% are not desirable because they may not be sustainable.
View Smith & Nephew's dividend history.

What other stocks do shareholders of Smith & Nephew own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Smith & Nephew investors own include Imperial Brands (IMB), Smith & Nephew (SNN), Alexion Pharmaceuticals (ALXN), Barclays (BARC), GSK (GSK), Diageo (DGE), Standard Chartered (STAN), Unilever (ULVR), British American Tobacco (BATS) and BHP Group (BHP).

What is Smith & Nephew's stock symbol?

Smith & Nephew trades on the London Stock Exchange (LON) under the ticker symbol "SN."

How do I buy shares of Smith & Nephew?

Shares of SN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Smith & Nephew's stock price today?

One share of SN stock can currently be purchased for approximately GBX 1,070.50.

How much money does Smith & Nephew make?

Smith & Nephew (LON:SN) has a market capitalization of £9.34 billion and generates £5.21 billion in revenue each year.

How many employees does Smith & Nephew have?

Smith & Nephew employs 18,369 workers across the globe.

How can I contact Smith & Nephew?

Smith & Nephew's mailing address is 15 Adam Street, LONDON, WC2N 6LA, United Kingdom. The official website for Smith & Nephew is www.smith-nephew.com. The company can be reached via phone at +44-20-74017646.

This page (LON:SN) was last updated on 8/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.